LALPATHLAB
Stock gave 20-25% growth in 2018 and almost 50% growth in 2019 during intra-year swings.
During 2020 fall, it gave 33% correction, and recovered entire fall mid-year.
By mid-2020 it was back to 2019 high.
From start of 2020H2, it appreciated 30% by end of CY2020.
Last weekly close, was at ATH [all time high] with volume, by breaking out from top wicks of previous weeks swing high.
Week RSI[14] = 69.47
Aggressive trader : Buy 50% Qty at current price, add 50% Qty after 4-5 trading session if price move in trade's direction.
Conservative trader: Buy 25% Qty at current price, add 25% Qty after price give pull-back near purple-dot line, add 50% after price move above 1st purchase in trade's direction.
LOSS EXIT:
Top purple-dot line : those holding for few days
Middle purple dot-line: those holding for few months
Bottom purple-dot line: those plan to hold for a year
Stock gave 20-25% growth in 2018 and almost 50% growth in 2019 during intra-year swings.
During 2020 fall, it gave 33% correction, and recovered entire fall mid-year.
By mid-2020 it was back to 2019 high.
From start of 2020H2, it appreciated 30% by end of CY2020.
Last weekly close, was at ATH [all time high] with volume, by breaking out from top wicks of previous weeks swing high.
Week RSI[14] = 69.47
Aggressive trader : Buy 50% Qty at current price, add 50% Qty after 4-5 trading session if price move in trade's direction.
Conservative trader: Buy 25% Qty at current price, add 25% Qty after price give pull-back near purple-dot line, add 50% after price move above 1st purchase in trade's direction.
LOSS EXIT:
Top purple-dot line : those holding for few days
Middle purple dot-line: those holding for few months
Bottom purple-dot line: those plan to hold for a year
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.